IDENTIFICATION OF RESIDUES IN THE N-TERMINAL ACIDIC DOMAIN OF HIV-1 VPR ESSENTIAL FOR VIRION INCORPORATION

被引:87
作者
MAHALINGAM, S
KHAN, SA
JABBAR, MA
MONKEN, CE
COLLMAN, RG
SRINIVASAN, A
机构
[1] THOMAS JEFFERSON UNIV,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19107
[2] INFIN BIOTECH RES & RESOURCE,UPLAND,PA 19015
[3] CLEVELAND CLIN FDN,DEPT MOLEC BIOL,CLEVELAND,OH 44195
[4] UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104
[5] THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107
[6] THOMAS JEFFERSON UNIV,INST BIOTECHNOL & ADV MOLEC MED,PHILADELPHIA,PA 19107
关键词
D O I
10.1006/viro.1995.1081
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vpr is one of the auxiliary proteins encoded by the HIV-I genome and is selectively incorporated into the virus particle. It has been shown that Vpr incorporation in the virus particle requires only the core protein Gag. In an effort to identify the domains of Vpr which are essential for incorporation into the HIV-I virion, site-specific mutagenesis of vpr was carried out Mutation of the highly conserved acidic residues in the N-terminal domain (amino acid positions 17-34) eliminated virion incorporation. These mutations disrupt a predicted amphipathic alpha-helical structure that is highly conserved among Vpr sequences. in contrast, alterations of the conserved cysteine (Cys76), basic domain (Arg87 and Lys95), and other residues (Gln65) did not impair the incorporation of Vpr into virus-like particles directed by HIV-1 Gag. The results presented here suggest that protein-protein interactions mediated through the putative helical domain of Vpr may participate in its incorporation into the virus particle. (C) l995 Academic Press. Inc.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 34 条
[1]   NEF INDUCES CD4 ENDOCYTOSIS - REQUIREMENT FOR A CRITICAL DILEUCINE MOTIF IN THE MEMBRANE-PROXIMAL CD4 CYTOPLASMIC DOMAIN [J].
AIKEN, C ;
KONNER, J ;
LANDAU, NR ;
LENBURG, ME ;
TRONO, D .
CELL, 1994, 76 (05) :853-864
[2]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[3]   ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TARGETED TO THE VPR GENE INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY HUMAN MACROPHAGES [J].
BALOTTA, C ;
LUSSO, P ;
CROWLEY, R ;
GALLO, RC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1993, 67 (07) :4409-4414
[4]   GENETIC-EVIDENCE THAT THE TAT PROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 CAN MULTIMERIZE IN THE EUKARYOTIC CELL-NUCLEUS [J].
BOGERD, HP ;
FRIDELL, RA ;
BLAIR, WS ;
CULLEN, BR .
JOURNAL OF VIROLOGY, 1993, 67 (08) :5030-5034
[5]  
COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN [J].
COHEN, EA ;
DEHNI, G ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3097-3099
[7]   AN INFECTIOUS MOLECULAR CLONE OF AN UNUSUAL MACROPHAGE-TROPIC AND HIGHLY CYTOPATHIC STRAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
COLLMAN, R ;
BALLIET, JW ;
GREGORY, SA ;
FRIEDMAN, H ;
KOLSON, DL ;
NATHANSON, N ;
SRINIVASAN, A .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7517-7521
[8]   VIRAL PROTEIN-R OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND TYPE-2 IS DISPENSABLE FOR REPLICATION AND CYTOPATHOGENICITY IN LYMPHOID-CELLS [J].
DEDERA, D ;
HU, W ;
VANDERHEYDEN, N ;
RATNER, L .
JOURNAL OF VIROLOGY, 1989, 63 (07) :3205-3208
[9]   USE OF A HYBRID VACCINIA VIRUS-T7 RNA-POLYMERASE SYSTEM FOR EXPRESSION OF TARGET GENES [J].
FUERST, TR ;
EARL, PL ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (07) :2538-2544
[10]   VPU PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENHANCES THE RELEASE OF CAPSIDS PRODUCED BY GAG GENE CONSTRUCTS OF WIDELY DIVERGENT RETROVIRUSES [J].
GOTTLINGER, HG ;
DORFMAN, T ;
COHEN, EA ;
HASELTINE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :7381-7385